pioneer 9 semaglutide Dose-response, efficacy, and safety of oral monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2/3a, randomised, controlled trial Efficacy of Oral Semaglutide: Overview

Premium Quality: Manufactured by Hikma Pharmaceuticals a global leader in injectable medications

What the GLP-1 class is, why it is prescription-only, how telehealth assessment works, and why eligibility is decided by a practitioner

An everything-but-the-kitchen-sink mapping study of GLP1- receptor agonists compared to other diabetes medications, where 175 health outcomes were assessed between the two groups, was published this year and it highlighted a number of slight risk increases with GLP-1 receptor agonists

After first use: room temp up to 56 days

PlexusDx explains why monotherapy is standard and how genetic testing helps identify your ideal single-agent approach

During the last two decades, kratom has been purported as a safer alternative to pharmaceutical and ...